載入...
Low dose rapamycin exacerbates autoimmune experimental uveitis.
Rapamycin, a potent immune modulator, is used to treat transplant rejection and some autoimmune diseases. Uveitis is a potentially severe inflammatory eye disease, and 2 clinical trials of treating uveitis with rapamycin are under way. Unexpectedly, recent research has demonstrated that low dose rap...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science (PLoS)
2012-01-01
|
叢編: | PLoS ONE |
在線閱讀: | http://europepmc.org/articles/PMC3344911?pdf=render |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|